Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
The body of a man has been found in the port of Marseille
Read More
The trial of Dahbia Benkired, 27, begins today, Friday, October 17th, 2025, in Paris. She stands accused of the 2022 torture, rape, and murder of 12-y...
Read More
The Monaco Business Group for the Fight Against Cancer, or GEMLUC, will fund two PhD theses in Monaco focused on high-grade brain cancers, including g...
Read More
The French National Assembly will today debate two motions of censure filed by the far-right National Rally and the far-left LFI, just days after new ...
Read More
The General Inspector of French Prisons has issued a report which is highly critical of the state of French prisons, including the one in Nice. Domini...
Read More
